XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 26.21%5.82B | 5.02%1.32B | 6.87%1.91B | 10.86%1.56B | 560.65%1.02B | 14.45%4.61B | -65.60%1.26B | 120.17%1.79B | 187.55%1.41B | 116.77%155M |
Net income from continuing operations | -29.54%6.66B | 61.22%1.9B | 452.44%1.7B | -13.07%1.52B | -75.10%1.55B | 598.82%9.45B | -70.10%1.18B | 225.31%307M | 254.75%1.74B | 614.56%6.22B |
Operating gains losses | 75.95%-1.67B | 88.06%-94M | -351.61%-1.01B | 450.97%544M | 82.73%-1.11B | -1,506.68%-6.95B | 21.06%-787M | 295.10%403M | -111.38%-155M | -23,840.74%-6.41B |
Depreciation and amortization | 0.42%1.18B | -3.56%298M | 7.19%313M | -29.58%50M | 3.16%523M | -0.42%1.18B | 127.13%309M | -39.42%292M | -86.24%71M | -61.74%507M |
Deferred tax | -3.22%962M | -21.16%395M | 661.54%198M | -73.98%51M | 17.34%318M | 488.17%994M | 1,573.53%501M | 100.00%26M | 21.74%196M | 834.48%271M |
Other non cash items | -195.88%-535M | -465.81%-428M | -3.73%749M | -6.60%-549M | -272.47%-307M | 125.91%558M | 101.72%117M | 12.43%778M | -22.91%-515M | 311.90%178M |
Change In working capital | -265.95%-697M | -264.39%-457M | -173.50%-147M | -164.23%-246M | 134.69%153M | -62.80%420M | -86.63%278M | 281.82%200M | 158.78%383M | 55.41%-441M |
-Change in receivables | -401.27%-1.19B | -247.58%-431M | -623.64%-864M | 94.95%-56M | -80.36%163M | 87.11%-237M | 34.74%-124M | 119.10%165M | -70.99%-1.11B | 705.84%830M |
-Change in inventory | -15.67%-1.53B | 8.94%-112M | 59.51%-215M | -97.53%15M | 4.63%-1.22B | -34.80%-1.32B | -109.87%-123M | -50.85%-531M | 153.24%608M | -74.18%-1.28B |
-Change in payables and accrued expense | -3.51%688M | 1,263.64%128M | -75.28%133M | -18.35%316M | 155.22%111M | -56.50%713M | 81.03%-11M | -8.19%538M | -72.44%387M | 31.40%-201M |
-Change in other working capital | 5.22%1.33B | -107.84%-42M | 2,753.57%799M | -205.04%-521M | 434.15%1.1B | -45.21%1.27B | -50.46%536M | -94.62%28M | -7.12%496M | 18.50%205M |
Cash from discontinued investing activities | -290.86%-1.11B | -101.11%-21M | -1,291.18%-405M | 29.84%-649M | 92.25%-32M | -69.30%580M | 121.39%1.88B | -94.43%34M | -1,667.80%-925M | -211.92%-413M |
Operating cash flow | -9.23%4.71B | -58.69%1.3B | -17.28%1.51B | 88.25%913M | 483.01%992M | -12.30%5.19B | -30.22%3.14B | 28.11%1.82B | -11.82%485M | 53.42%-259M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -107.23%-556M | -87.89%341M | -58.04%1.09B | -373.68%-2.76B | -39.64%769M | -25.81%7.69B | -66.07%2.82B | 288.92%2.6B | -30.12%1.01B | 3,638.89%1.27B |
Net PPE purchase and sale | -14.46%-918M | -4.51%-255M | -16.20%-251M | 37.25%-32M | -30.58%-380M | -57.56%-802M | -280.74%-244M | -31.71%-216M | 81.04%-51M | -37.91%-291M |
Net business purchase and sale | -37.36%5.61B | -41.38%1.15B | -34.98%1.78B | -96.69%74M | 28.89%2.61B | 90.62%8.96B | 204.49%1.97B | 901.10%2.73B | -9.79%2.24B | 55.53%2.03B |
Net investment purchase and sale | 2.33%-963M | -204.33%-265M | 89.36%267M | 0.57%176M | 26.67%-1.14B | -12.56%-986M | -18.85%254M | -15.57%141M | 1,558.33%175M | -15.77%-1.56B |
Net other investing changes | -927.99%-4.29B | -134.89%-292M | -1,071.67%-703M | -119.88%-2.98B | -129.16%-319M | -92.65%518M | -88.38%837M | -115.27%-60M | -73.24%-1.35B | 359.66%1.09B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -142.00%-1.67B | -80.95%321M | -39.22%1.49B | -363.75%-4.29B | 144.99%808M | 74.76%3.97B | 148.53%1.69B | 3,561.19%2.45B | -17.47%1.63B | -304.50%-1.8B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 36.94%-6.63B | -525.00%-2.18B | 61.75%-1.46B | -149.33%-2.79B | 96.10%-204M | 22.37%-10.51B | 95.91%-348M | -95.39%-3.81B | 32.39%-1.12B | -265.48%-5.23B |
Net issuance payments of debt | 76.56%-786M | 57.58%-56M | 81.73%-116M | 64.28%-279M | 81.44%-335M | 69.65%-3.35B | 98.34%-132M | 43.81%-635M | -2.76%-781M | -47.71%-1.81B |
Net common stock issuance | -372.59%-5.83B | -479.17%-1.67B | -390.73%-1.54B | -612.38%-2.3B | -4.21%-322M | -17.65%-1.23B | 20.00%-288M | 1.57%-313M | 2.42%-323M | -692.31%-309M |
Net preferred stock issuance | --0 | --0 | --0 | --0 | --0 | -3,924.31%-5.8B | --0 | -2,587.50%-2.8B | --0 | ---3B |
Cash dividends paid | -71.14%-1.01B | -247.73%-306M | -103.97%-308M | -109.52%-308M | 57.64%-86M | 7.82%-589M | 52.17%-88M | 6.21%-151M | 4.55%-147M | -45.00%-203M |
Net other financing activities | 116.81%993M | -191.19%-145M | 526.25%501M | -26.32%98M | 526.74%539M | 169.08%458M | 893.75%159M | 133.47%80M | 132.44%133M | 386.67%86M |
Cash from discontinued financing activities | -105.16%-98M | 0 | 0 | -122.73%-98M | 0 | -76.13%1.9B | -100.57%-46M | 71.43%-10M | -69.23%-44M | 7,239.29%2B |
Financing cash flow | 21.91%-6.73B | -450.63%-2.18B | 61.85%-1.46B | -148.54%-2.89B | 93.69%-204M | -54.22%-8.61B | 13.76%-395M | -92.45%-3.82B | 30.87%-1.16B | -121.52%-3.23B |
Net cash flow | ||||||||||
Beginning cash position | 3.47%19.76B | 23.47%15.1B | 15.53%13.55B | 56.80%19.9B | 3.47%19.76B | 13.25%19.09B | -2.49%12.23B | -11.36%11.73B | -3.13%12.69B | 13.25%19.09B |
Current changes in cash | -55.61%-5.01B | -111.72%-416M | 117.78%1.47B | -541.56%-6.27B | 103.17%205M | -41.99%-3.22B | 149.23%3.55B | 305.17%675M | -404.36%-977M | -75.56%-6.47B |
Effect of exchange rate changes | -260.83%-193M | -163.98%-135M | 150.00%85M | -685.71%-82M | -193.85%-61M | 132.52%120M | -16.93%211M | 52.38%-170M | 107.33%14M | 186.67%65M |
End cash Position | -9.00%14.55B | -9.00%14.55B | 23.47%15.1B | 15.53%13.55B | 56.80%19.9B | 12.44%15.99B | 12.44%15.99B | -2.49%12.23B | -11.36%11.73B | -3.13%12.69B |
Free cash flow | -15.00%3.68B | -64.36%1.03B | -22.42%1.24B | 112.47%835M | 202.51%571M | -17.66%4.33B | -37.70%2.89B | 36.72%1.6B | 50.00%393M | 31.82%-557M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |